Atazanavir (Reyataz®) is a protease inhibitor that is NOT used in infants younger than 3 months because it may cause:
A) kernicterus
B) hepatitis
C) brain damage
D) aplastic anemia
A) kernicterus
A) Atazanavir (Reyataz®) is a protease inhibitor that is not used in infants younger than 3 months because it may cause kernicterus. It is used in combination with other antiretrovirals for HIV-1 infection.
You might also like to view...
Which of the following statements regarding ignition-resistant construction is MOST accurate?
A) Requirements for ignition-resistant construction are the same regardless of jurisdiction or area. B) The National Fire Protection Association publishes the International Wildland-Urban Interface Code. C) Ignition-resistant requirements include a three-hour fire-resistive rating when exposed from the outside. D) Ignition-resistant construction is intended to decrease vulnerability of structures to exposure from wildland fires.
Which of the following features is characteristic of bisphosphonates?
A) Osteoblast inhibitor B) Binds to soft tissue C) Short half-life D) Long half-life